Pontus Berganäs

Associate, Stockholm

Corporate Advisory, Equity Capital Markets, Public M&A

Contact

Pontus Kittel Berganäs is a Stockholm-based Associate working with Roschier’s Corporate Advisory, Equity Capital Markets and Public M&A practices. Pontus joined Roschier in 2021.

Work highlights

Pontus Kittel Berganäs’s experience includes advising:

  • Frazier Life Sciences in its additional USD 10 million investment in Egetis Therapeutics;
  • CVC in the SEK 1.1 billion sell-down of shares in Synsam;
  • TA Associates in the fully underwritten SEK 4.3 billion rights issue in Elos Medtech;
  • Cargill in an offtake agreement and the commitment to invest in Nordic Iron Ore;
  • Navamedic in the recommended cash offer to acquire Sensidose;
  • Vinted in the SEK 315 million public offer for all shares in Rebelle;
  • Aareon AG in its acquisition and delisting of Momentum Software Group
  • Braathens Regional Airlines in connection with AMF’s SEK 200 million investment;
  • TA Associates in connection with the public tender offer for Elos Medtech.
Career

Roschier (2021-)

Education

Uppsala University, LL.M., (2021)

Languages

English, Swedish